Abstract
Brachyury is a transcription factor which is required for posterior mesoderm formation and differentiation as well as for notochord development during embryogenesis. Due to its expression in the neoplastic cells of chordoma, a malignant tumour deriving from notochordal remnants, but not in tumors showing a similar histology, brachyury has been proposed as a diagnostic marker of this neoplasia. Though commonly considered a hallmark of chordoma, the expression of brachyury has been also documented in the stromal cells of hemangioblastoma (HBL), a slow growing tumor which may involve the central nervous system (CNS) and, rarely, the kidney. Herein we review the role of brachyury immunohistochemical detection in the identification and differential diagnosis of chordoma and HBL towards histological mimickers and suggest that brachyury is added to the panel of immunohistochemical markers for the recognition of HBL in routinary practice, principally in unusual sites.
Highlights
Brachyury is a transcription factor encoded by T, a member of the T-box gene family, and required for posterior mesoderm formation and differentiation [1] as well as for notochord development [2]
Due to its expression in the neoplastic cells of chordoma, a malignant tumour deriving from notochordal remnants, but not in tumors showing a similar histology, brachyury has been proposed as a diagnostic marker of this neoplasia
Though commonly considered a hallmark of chordoma, the expression of brachyury has been documented in the stromal cells of hemangioblastoma (HBL), a slow growing tumor which may involve the central nervous system (CNS) and, rarely, the kidney
Summary
Brachyury is a transcription factor encoded by T, a member of the T-box gene family, and required for posterior mesoderm formation and differentiation [1] as well as for notochord development [2]. In accordance with its function, brachyury is expressed in all nascent mesoderm [2, 3], in the embryo. Brachyury expression has been found in chordoma [4], a malignant tumor which recapitulates notochord and derives from small collections of notochordal cells which may persist into the adult life [5]. There is evidence that chordoma is not the only tumour expressing brachyury. The expression of this protein has been documented in hemangioblastoma (HBL) [6, 7, 13, 14], a slow growing vascular tumour, which origins from mesoderm derived, embryologically arrested hemangioblasts [4, 13], which express this protein [15]. The use of brachyury immunohistochemical staining for the differential diagnosis of chordoma and HBL towards neoplastic histological mimickers occurring in the same sites is discussed
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
